
Medtronic highlights evolving diabetes strategy, Astellas pairs with Swiss biotech in $760M deal (Morning Read)
Medtronic highlighted a shift in its diabetes strategy towards smaller deals in the latest quarterly earnings report.
Medtronic highlighted a shift in its diabetes strategy towards smaller deals in the latest quarterly earnings report.